These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 17020540

  • 21. [Effect of astraglus injection on serum apoptosis relevant factors in patients with chronic heart failure].
    Zhang JG, Yang N, He H.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2005 May; 25(5):400-3. PubMed ID: 15957829
    [Abstract] [Full Text] [Related]

  • 22. Effects of a DA2/alpha2 agonist and a beta1-blocker in combination with an ACE inhibitor on adrenergic activity and left ventricular remodeling in an experimental model of left ventricular dysfunction after coronary artery occlusion.
    Masson S, Masseroli M, Fiordaliso F, Calvillo L, D'Aquila S, Bernasconi R, Garrido G, Torri M, Razzetti R, Bongrani S, Latini R.
    J Cardiovasc Pharmacol; 1999 Sep; 34(3):321-6. PubMed ID: 10470987
    [Abstract] [Full Text] [Related]

  • 23. The Effect of Autoantibody against M2-Muscarinic Acetylcholine Receptor in Heart Failure Patients on Digoxin Treatment.
    Hou D, Fan Z, Xu L, Wang H, Zhang Z, Ma G, Xu X, Wang X, Zhang J, Liu J, Zhang L.
    Cardiology; 2018 Sep; 141(1):9-17. PubMed ID: 30293082
    [Abstract] [Full Text] [Related]

  • 24. Serum and urinary magnesium during treatment of patients with chronic congestive heart failure.
    Oladapo OO, Falase AO.
    Afr J Med Med Sci; 2000 Sep; 29(3-4):301-3. PubMed ID: 11714011
    [Abstract] [Full Text] [Related]

  • 25. Effects of angiotensin-converting enzyme inhibitors and digoxin on health outcomes of very old patients with heart failure. SAGE Study Group. Systematic Assessment of Geriatric drug use via Epidemiology.
    Gambassi G, Lapane KL, Sgadari A, Carbonin P, Gatsonis C, Lipsitz LA, Mor V, Bernabei R.
    Arch Intern Med; 2000 Jan 10; 160(1):53-60. PubMed ID: 10632305
    [Abstract] [Full Text] [Related]

  • 26. Metoprolol reverses left ventricular remodeling in patients with asymptomatic systolic dysfunction: the REversal of VEntricular Remodeling with Toprol-XL (REVERT) trial.
    Colucci WS, Kolias TJ, Adams KF, Armstrong WF, Ghali JK, Gottlieb SS, Greenberg B, Klibaner MI, Kukin ML, Sugg JE, REVERT Study Group.
    Circulation; 2007 Jul 03; 116(1):49-56. PubMed ID: 17576868
    [Abstract] [Full Text] [Related]

  • 27. Review of randomized trials of digoxin therapy in patients with chronic heart failure.
    Gheorghiade M, Zarowitz BJ.
    Am J Cardiol; 1992 Jun 04; 69(18):48G-62G; discussion 62G-63G. PubMed ID: 1626492
    [Abstract] [Full Text] [Related]

  • 28. Effects of losartan and captopril on left ventricular volumes in elderly patients with heart failure: results of the ELITE ventricular function substudy.
    Konstam MA, Patten RD, Thomas I, Ramahi T, La Bresh K, Goldman S, Lewis W, Gradman A, Self KS, Bittner V, Rand W, Kinan D, Smith JJ, Ford T, Segal R, Udelson JE.
    Am Heart J; 2000 Jun 04; 139(6):1081-7. PubMed ID: 10827391
    [Abstract] [Full Text] [Related]

  • 29. Flexible versus nonflexible mitral valve rings for congestive heart failure: differential durability of repair.
    Spoor MT, Geltz A, Bolling SF.
    Circulation; 2006 Jul 04; 114(1 Suppl):I67-71. PubMed ID: 16820648
    [Abstract] [Full Text] [Related]

  • 30. A comparison of the efficacy and safety of ramipril and digoxin added to maintenance diuretic treatment in patients with chronic heart failure.
    Kholeif MA, Pringle S, Kesson E, Murray G, Kennedy JA, Lorimer AR, Stock JK, Brown JJ.
    J Cardiovasc Pharmacol; 1991 Jul 04; 18 Suppl 2():S180-3. PubMed ID: 1725036
    [Abstract] [Full Text] [Related]

  • 31. Factors influencing recovery of left ventricular structure in patients with chronic heart failure.
    Duan HY, Wu XS, Han ZH, Guo YF, Fang SJ, Zhang XX, Wang CM.
    Chin Med J (Engl); 2011 Sep 04; 124(18):2868-73. PubMed ID: 22040494
    [Abstract] [Full Text] [Related]

  • 32. Diastolic heart failure and left ventricular diastolic dysfunction: what we know, and what we don't know!
    Shammas RL, Khan NU, Nekkanti R, Movahed A.
    Int J Cardiol; 2007 Feb 14; 115(3):284-92. PubMed ID: 16904774
    [Abstract] [Full Text] [Related]

  • 33. Effects of long-term monotherapy with enalapril, metoprolol, and digoxin on the progression of left ventricular dysfunction and dilation in dogs with reduced ejection fraction.
    Sabbah HN, Shimoyama H, Kono T, Gupta RC, Sharov VG, Scicli G, Levine TB, Goldstein S.
    Circulation; 1994 Jun 14; 89(6):2852-9. PubMed ID: 8205701
    [Abstract] [Full Text] [Related]

  • 34. Pharmacoeconomic considerations in assessing and selecting congestive heart failure therapies.
    Levy E, Levy P.
    Pharmacoeconomics; 2002 Jun 14; 20(14):963-77. PubMed ID: 12403637
    [Abstract] [Full Text] [Related]

  • 35. Impact of beta2-adrenoreceptor gene variants on cardiac cavity size and systolic function in idiopathic dilated cardiomyopathy.
    Badenhorst D, Norton GR, Sliwa K, Brooksbank R, Essop R, Sareli P, Woodiwiss AJ.
    Pharmacogenomics J; 2007 Oct 14; 7(5):339-45. PubMed ID: 17117186
    [Abstract] [Full Text] [Related]

  • 36. Community pharmacist outreach program directed at physicians treating congestive heart failure.
    Turner CJ, Parfrey P, Ryan K, Miller R, Brown A.
    Am J Health Syst Pharm; 2000 Apr 15; 57(8):747-52. PubMed ID: 10786260
    [Abstract] [Full Text] [Related]

  • 37. Patterns of physician use of angiotensin converting enzyme inhibitors in the inpatient treatment of congestive heart failure.
    Ghali JK, Giles T, Gonzales M, Horswell R, Kumar S, Lejuene A, Livaudais GF, Sarkar IC.
    J La State Med Soc; 1997 Dec 15; 149(12):474-84. PubMed ID: 9425858
    [Abstract] [Full Text] [Related]

  • 38. [Drug treatment of cardiac insufficiency with systolic dysfunction].
    Follath F.
    Praxis (Bern 1994); 1997 Feb 11; 86(7):254-7. PubMed ID: 9139344
    [Abstract] [Full Text] [Related]

  • 39. Circulating levels of soluble Fas ligand and left ventricular remodeling after acute myocardial infarction (from the REVE-2 study).
    Fertin M, Bauters A, Pinet F, Bauters C.
    J Cardiol; 2012 Aug 11; 60(2):93-7. PubMed ID: 22521430
    [Abstract] [Full Text] [Related]

  • 40. Digoxin, converting-enzyme inhibition (quinapril), and the combination in patients with congestive heart failure functional class II and sinus rhythm.
    Kromer EP, Elsner D, Riegger GA.
    J Cardiovasc Pharmacol; 1990 Jul 11; 16(1):9-14. PubMed ID: 1696671
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.